May 28, 2024, 14:58 by

We are announcing our 2024 recipient of the Julie Swedberg YOLO Cancer Research Award of $150,000. This is a new research award named in honor of Julie Swedberg, who died from lung cancer in 2023 as a 48-year-old non-smoker. Jessica Konen, PhD, of Emory University Winship Cancer Institute, will receive this national award in recognition and support of her work entitled MiR-29 as a master regulator of anti-tumor immunity. The project focuses on defining a novel mechanism of resistance to immune checkpoint inhibitor treatments in lung cancer.

May 28, 2024, 05:00 by User Not Found

Clinical Research News | Blackstone launches the Blackstone Life Sciences portfolio company Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation; the Patient-Centered Outcomes Research Institute secures approval of funding awards to support new patient-centered comparative clinical effectiveness research studies; Laurence Belfer gifts funds to the University of Texas MD Anderson Cancer Center to strengthen neurodegeneration research through the Belfer Neurodegeneration Consortium, a transformative multi-institutional initiative to advance the study and treatment of Alzheimer’s disease; more.

May 24, 2024, 07:40 by

May 24, 2024, 07:40 by

PathAI, a global leader in AI-powered pathology, and Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced a multi-year strategic partnership to develop curated multimodal datasets that pair PathAI’s PathExplore1 artificial intelligence (AI) tumor microenvironment (TME) quantification panel with Aster Insights’ Avatar clinical, molecular, and digital pathology imaging data. By combining their respective best-in-class platforms, PathAI and Aster Insights will be able to expedite the development of novel insights to accelerate the discovery and development of new treatments for patients with cancer.

May 24, 2024, 05:00 by User Not Found

Clinical Research News | The clinical trials landscape is evolving with more data, increased investment in personalized medicines and a shift toward decentralized and hybrid clinical trials. At the same time, the industry is attempting to become more efficient and harness new technologies and data science in operations.

May 23, 2024, 08:09 by

May 22, 2024, 07:33 by

May 22, 2024, 05:00 by User Not Found

Clinical Research News | A consortium of pancreatic cancer researchers sharing information in real time has shown that an oral pan-RAS inhibitor known as RMC-7977, developed by Revolution Medicines, effectively targets the common cancer-causing RAS proteins while minimally impacting normal cells—and did so across a comprehensive range of preclinical models in a series of similar experiments.

May 21, 2024, 09:08 by

D'OXYVA is thrilled to launch its nationwide at-home safety and efficacy study, open to participants across the U.S.

May 21, 2024, 09:08 by

May 21, 2024, 05:28 by User Not Found

Clinical Research News | In the not-too-distant future, disorders of the brain could be treated with the same precision as heart disease and cancer. The means will be a therapeutic brain-computer interface (BCI) the size of a small blueberry for people suffering from treatment-resistant depression that uses a similar type of implant technology as Elon Musk’s Neuralink for helping paralyzed people speak.

May 20, 2024, 08:24 by

May 20, 2024, 08:24 by

Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.

May 20, 2024, 08:24 by

Dr. Vince Clinical Research (DVCR) today announced the appointment of Sheldon Preskorn, M.D., as its Senior Vice President of Neuroscience.

May 20, 2024, 08:24 by

Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).

May 17, 2024, 07:34 by

May 17, 2024, 07:34 by

https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime

May 17, 2024, 07:34 by

https://www.prnewswire.com/news-releases/mdclone-earns-fourth-consecutive-best-healthcare-big-data-platform-award-from-medtech-breakthrough-302147956.html?tc=eml_cleartime

May 17, 2024, 07:34 by

Today, The British Journal of Nutrition published a study that found the consumption of a daily prebiotic fibre supplement helped to improve insulin sensitivity and other important health markers in patients with pre-diabetes.

May 17, 2024, 05:30 by User Not Found

Clinical Research News | Clinical trials are the bedrock for developing advanced treatments within the life-saving field of cell and gene therapy. Despite significant strides, these trials encounter multi-faceted challenges that threaten to impede the progress of important new therapies.